Terminated × Observational × Head and Neck Neoplasms × Clear all
NCT04106167 2023-09-21

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Fate Therapeutics

Terminated
20 enrolled
NCT02900248 2019-04-02

N1

CureOne

Terminated
23 enrolled
NCT01096381 2012-02-27

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Vanderbilt-Ingram Cancer Center

Terminated
8 enrolled